21 – 30 of 33
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Characteristics of Recurrent Ischemic Stroke after Embolic Stroke of Undetermined Source : Secondary Analysis of a Randomized Clinical Trial
(
- Contribution to journal › Article
-
Mark
Diagnostic Performance of RO948 F 18 Tau Positron Emission Tomography in the Differentiation of Alzheimer Disease from Other Neurodegenerative Disorders
(
- Contribution to journal › Article
-
Mark
Assessment of Demographic, Genetic, and Imaging Variables Associated with Brain Resilience and Cognitive Resilience to Pathological Tau in Patients with Alzheimer Disease
(
- Contribution to journal › Article
- 2019
-
Mark
Staging β -Amyloid Pathology with Amyloid Positron Emission Tomography
(
- Contribution to journal › Article
-
Mark
Performance of Fully Automated Plasma Assays as Screening Tests for Alzheimer Disease-Related β-Amyloid Status
(
- Contribution to journal › Article
-
Mark
Association between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients with Alzheimer Disease
(
- Contribution to journal › Article
-
Mark
Correlation of in Vivo [18F]Flortaucipir with Postmortem Alzheimer Disease Tau Pathology
(
- Contribution to journal › Article
-
Mark
Serum Neurofilament Light Chain for Prognosis of Outcome after Cardiac Arrest
(
- Contribution to journal › Article
- 2018
-
Mark
Use of flutemetamol F18-labeled positron emission tomography and other biomarkers to assess risk of clinical progression in patients with amnestic mild cognitive impairment
(
- Contribution to journal › Article
- 2017
-
Mark
Concordance between different amyloid immunoassays and Visual amyloid positron emission tomographic assessment
(
- Contribution to journal › Article